does semaglutide help stop drinking GLP-1 medications: The next big thing in alcohol use disorder treatment? – Recovery Research Institute Semaglutide and Tirzepatide reduce alcohol

Schedule your free consultation for our weight management injections today!

Key Features Wegovy FlexTouch 0.25 mg is a pre-filled, single-patient-use injection pen containing semaglutide, a GLP-1 receptor agonist indicated for chronic weight management in adults with obesity or overweight with weight-related comorbidities

Oral semaglutide can cause nausea, vomiting, and appetite suppression in the first weeks of treatment

Supervised weekly injections reduce hunger, boost metabolism, and support long-term results

Metabolic Health Encourages balanced insulin response and steady energy throughout the day

Since the risk of nutrient deficiencies is very real, logging your food ensures youre eating enough protein, fiber, healthy fats, and micronutrients to help your body thrive